Published in J Chromatogr on August 11, 1977
Physiological disposition and metabolism of timolol in man and laboratory animals. Drug Metab Dispos (1976) 1.14
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J Pharmacol Exp Ther (1988) 1.11
Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Dispos (1975) 1.05
Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. J Pharmacol Exp Ther (1967) 1.01
Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man. Drug Metab Dispos (1974) 0.99
Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man. J Pharmacol Exp Ther (1971) 0.99
Metabolism of dimethyl sulphoxide to dimethyl sulphone in the rat and man. Nature (1966) 0.88
Plasma levels of a new pelletized form of amitriptyline for maintenance therapy. J Clin Pharmacol (1975) 0.87
Phenylacetone oxime--an intermediate in the oxidative deamination of amphetamine. Biochem Pharmacol (1971) 0.86
Further studies on the metabolism of carbidopa, (minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate, in the human, Rhesus monkey, dog, and rat. J Med Chem (1975) 0.83
Comparative disposition of sulindac and metabolites in five species. Biochem Pharmacol (1978) 0.82
Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Drug Metab Dispos (1983) 0.81
Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys. J Pharm Sci (1972) 0.81
The effect of halofenate or halofenate free acid on human, rat and guinea pig platelet aggregation. Thromb Haemost (1976) 0.81
Absorption, distribution and metabolism of dimethylsulfoxide in the rat, rabbit and guinea pig. J Pharmacol Exp Ther (1966) 0.81
Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man. Drug Metab Dispos (1979) 0.79
Species differences in drug metabolism. Annu Rev Pharmacol (1970) 0.78
Plasma levels and bioavailability of cyclobenzaprine in human subjects. J Clin Pharmacol (1978) 0.78
GLC determination of cyclobenzaprine in plasma and urine. J Pharm Sci (1976) 0.77
Determination of cyproheptadine in plasma and urine by GLC with a nitrogen-sensitive detector. J Pharm Sci (1983) 0.76
Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies. Biopharm Drug Dispos (1988) 0.76
Physiologic disposition and metabolic fate of indomethacin analogs. II. 1-(p-chlorobenzoyl)-5-dimethylamino-2-methylindole-3-acetic acid. J Pharm Sci (1971) 0.75
Physiological disposition and urinary metabolites of cyproheptadine in the dog, rat, and cat. Drug Metab Dispos (1975) 0.75
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes. Drug Metab Dispos (1989) 0.75
Metabolism of a pharmacologically active pyrrolidine derivative (prolintane) by lactam formation. Experientia (1972) 0.75
Epoxide metabolites of protriptyline in rat urine. Drug Metab Dispos (1975) 0.75
Gas-liquid chromatographic determination of nanogram amounts of cyclobenzaprine in plasma using a nitrogen detector. J Chromatogr (1976) 0.75
A technique for the improvement of gas chromatographic properties of tertiary amines such as amitriptyline. J Chromatogr (1968) 0.75
GLC method for quantitative determination of amitriptyline in human plasma. J Pharm Sci (1974) 0.75
A new method for assay of radioactive dimethyl sulfoxide and its metabolite, dimethyl sulfone. Experientia (1966) 0.75
Phenylacetone oxime--an intermediate in amphetamine deamination. Drug Metab Dispos (1974) 0.75
Intermediates in drug metabolism reactions. Drug Metab Rev (1973) 0.75
Urinary metabolites of amitriptyline in the dog. Drug Metab Dispos (1977) 0.75
Metabolism of cyclobenzaprine in the dog. Drug Metab Dispos (1978) 0.75
Bioavailability assessment under quasi- and nonsteady-state conditions III: Application. J Pharm Sci (1976) 0.75
GLC determination of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo [a,d]cyclohepten-5-ylidene)piperidine in human plasma and urine. J Pharm Sci (1983) 0.75
Physiologic disposition and metabolism of an anti-ulcer agent, N-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)-N',N'-dimethylurea, in rats, dogs, and monkeys. Drug Metab Dispos (1982) 0.75
Metabolism of protriptyline by rabbit liver in vitro. Pharmacology (1979) 0.75
Determination of various drugs in rodent diet mixtures. J Chromatogr (1977) 0.75
Bioavailability of indomethacin in man. Ann Clin Res (1974) 0.75
The disposition and metabolism of an orexigenic agent, 10,11-dihydro-5-(1-methyl-4-piperidinylidene)-5H-dibenzo[a,d]cyclohepten-3-carboxylic acid, in the rat, dog, and cat. Drug Metab Dispos (1982) 0.75
GLC analysis of lidocaine in plasma using a novel nitrogen-sensitive detector. J Pharm Sci (1976) 0.75
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys. Xenobiotica (1991) 0.75
Physiologic disposition and metabolic fate of indomethacin analogs. I. 1-p-chlorobenzylidenyl-5-methoxy-2-methylindene-3-acetic acid. J Pharm Sci (1971) 0.75